At a glance

ClinicalIndex Comparison Record

N/ACompleted· 27 enrolled

Drug / intervention

Receiver-in-canal hearing instrument; Manufacturer A +1 moredevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04839289

NCT04839289N/ACompleted

Compare CT.gov

A Study to Compare Patient Perceptions of Two Different Hearing Aid Signal Processing Philosophies

Sonova AG·interventional·Posted Apr 9, 2021·Updated Mar 22, 2023

In Brief

A clinical study evaluating Receiver-in-canal hearing instrument; Manufacturer A and Receiver-in-canal hearing instrument; Manufacturer B for Hearing Loss, Sensorineural. Completed, enrolled 27 participants across 1 site.

Detailed Summary

Participants will be fit with each of two hearing instruments in an ABA cross-over design. The study will consist of a total of three approximately 10-day home trials with the devices. Participants will be asked to provide qualitative feedback to investigators regarding the performance of and their preference for each hearing instrument.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHearing Loss, Sensorineural

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

20222023202420252026

First PostedApr 2021

Enrollment StartJul 2021

Primary CompletionAug 2021

TodayJul 2026

First PostedApr 9, 2021

Enrollment StartJul 1, 2021

Primary CompletionAug 31, 2021

TodayJul 2, 2026

Enrollment to primary: 2 monthsPosted 5.2 years ago

Interventions

Receiver-in-canal hearing instrument; Manufacturer Adevice

Commercially available receiver-in-canal hearing instrument from manufacturer A

Receiver-in-canal hearing instrument; Manufacturer Bdevice

Commercially available receiver-in-canal hearing instrument from manufacturer B